KR20020013876A - 개선된 인산화 방법 및 이에 의해 제조된 화합물 - Google Patents

개선된 인산화 방법 및 이에 의해 제조된 화합물 Download PDF

Info

Publication number
KR20020013876A
KR20020013876A KR1020017014206A KR20017014206A KR20020013876A KR 20020013876 A KR20020013876 A KR 20020013876A KR 1020017014206 A KR1020017014206 A KR 1020017014206A KR 20017014206 A KR20017014206 A KR 20017014206A KR 20020013876 A KR20020013876 A KR 20020013876A
Authority
KR
South Korea
Prior art keywords
alcohols
complex
temperature
phosphorylation
complex alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020017014206A
Other languages
English (en)
Korean (ko)
Inventor
시몬마이클웨스트
Original Assignee
웨스트 시몬 마이클
스위그 피티와이 리미티드 에이.씨.엔.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU2000/000038 external-priority patent/WO2000043380A1/en
Application filed by 웨스트 시몬 마이클, 스위그 피티와이 리미티드 에이.씨.엔. filed Critical 웨스트 시몬 마이클
Priority claimed from PCT/AU2000/000452 external-priority patent/WO2000069865A1/en
Publication of KR20020013876A publication Critical patent/KR20020013876A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/11Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
KR1020017014206A 1999-05-14 2000-05-12 개선된 인산화 방법 및 이에 의해 제조된 화합물 Ceased KR20020013876A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPQ0374A AUPQ037499A0 (en) 1999-05-14 1999-05-14 Improved process for phosphorylation and compounds produced by this method
AUPQ0374 1999-05-14
PCT/AU2000/000038 WO2000043380A1 (en) 1999-01-25 2000-01-25 Recovery of chroman derivatives
AUPCT/AU2000/00038 2000-01-25
PCT/AU2000/000452 WO2000069865A1 (en) 1999-05-14 2000-05-12 Improved process for phosphorylation and compounds produced by this process

Publications (1)

Publication Number Publication Date
KR20020013876A true KR20020013876A (ko) 2002-02-21

Family

ID=3814578

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017014206A Ceased KR20020013876A (ko) 1999-05-14 2000-05-12 개선된 인산화 방법 및 이에 의해 제조된 화합물

Country Status (7)

Country Link
US (1) US6579995B1 (https=)
JP (1) JP4932995B2 (https=)
KR (1) KR20020013876A (https=)
AT (1) ATE377015T1 (https=)
AU (1) AUPQ037499A0 (https=)
BR (1) BR0011523B1 (https=)
DE (1) DE60036940T2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190100298A (ko) * 2016-12-21 2019-08-28 아베초 바이오테크놀로지 리미티드 방법

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140141D1 (de) * 2000-11-14 2009-11-19 Vital Health Sciences Pty Ltd Zusammensetzungen umfassend Komplexe von Tocopherolphosphatderivaten
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
BR0211673A (pt) * 2001-07-27 2004-07-13 Vital Health Sciences Pty Ltd Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
ATE487456T1 (de) * 2001-12-13 2010-11-15 Vital Health Sciences Pty Ltd Transdermaler transport von verbindungen
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
EP1589964B1 (en) * 2003-01-17 2011-11-23 Vital Health Sciences Pty Ltd. Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
JP4847437B2 (ja) * 2004-03-03 2011-12-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド アルカロイド製剤
BRPI0513673B8 (pt) * 2004-08-03 2021-07-27 Vital Health Sciences Pty Ltd método para produzir um medicamento para aumentar a eficácia e o transporte dos compostos biologicamente ativos enteralmente administrados, e composição farmacêutica
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
US9168216B2 (en) * 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
WO2007070981A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd Compounds having cytokine modulating properties
US8728990B2 (en) 2009-12-04 2014-05-20 Elementis Specialties, Inc. Phosphate ester oil gellant
EP2531047B1 (en) 2010-02-05 2024-11-13 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5022535B1 (https=) * 1970-05-12 1975-07-31
JPS5239013B1 (https=) * 1970-05-21 1977-10-03
US4141938A (en) 1976-10-07 1979-02-27 Hoechst Aktiengesellschaft Production of acid orthophosphoric acid ester mixtures
JPH0247997B2 (ja) 1983-02-25 1990-10-23 Sanyo Chemical Ind Ltd Rinsanesuterunoseizoho
JPS62195393A (ja) 1986-02-21 1987-08-28 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造方法
JPS6393791A (ja) * 1986-10-08 1988-04-25 Nippon Shokubai Kagaku Kogyo Co Ltd リン酸エステルおよびその製法
DE3702766A1 (de) 1987-01-30 1988-08-11 Henkel Kgaa Verfahren zur herstellung und isolierung von monoalkylphosphorsaeureestern
IT1236843B (it) * 1989-11-22 1993-04-21 Simes Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
US5741518A (en) * 1992-08-03 1998-04-21 L'oreal Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids
US5554781A (en) * 1994-03-30 1996-09-10 Reierson; Robert L. Monoalkyl phosphonic acid ester production process
JPH07316170A (ja) 1994-05-24 1995-12-05 Kao Corp リン酸モノエステルの製造法
JP3526940B2 (ja) 1995-01-11 2004-05-17 花王株式会社 リン酸エステルの製造法
FR2730928B1 (fr) * 1995-02-23 1997-04-04 Oreal Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
JPH08231564A (ja) * 1995-02-28 1996-09-10 Nippon Shokubai Co Ltd リン酸エステルおよびその製造方法並びにリン酸エステル重合体
JP3197787B2 (ja) 1995-05-17 2001-08-13 花王株式会社 分岐二量化アルキルリン酸塩基性アミノ酸塩の製造方法
FR2741263B1 (fr) * 1995-11-22 1997-12-26 Oreal Composition comprenant une dispersion aqueuse de vesicules lipidiques encapsulant un filtre uv a fonction acide et utilisations en application topique
JPH1045783A (ja) * 1996-07-29 1998-02-17 Showa Denko Kk ヒドロキシクロマン誘導体リン酸エステルの製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190100298A (ko) * 2016-12-21 2019-08-28 아베초 바이오테크놀로지 리미티드 방법

Also Published As

Publication number Publication date
US6579995B1 (en) 2003-06-17
JP4932995B2 (ja) 2012-05-16
BR0011523B1 (pt) 2014-09-30
DE60036940T2 (de) 2008-08-14
ATE377015T1 (de) 2007-11-15
DE60036940D1 (de) 2007-12-13
AUPQ037499A0 (en) 1999-06-10
BR0011523A (pt) 2002-03-26
JP2003526623A (ja) 2003-09-09

Similar Documents

Publication Publication Date Title
KR20020013876A (ko) 개선된 인산화 방법 및 이에 의해 제조된 화합물
EP0127471B1 (en) Phosporic acid diesters, their salts, compositions containing them and a process for producing said diesters and salts
DE3874352T2 (de) Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten.
EP1178994B1 (en) Improved process for phosphorylation
KR19980081133A (ko) 식물성 라이소레시틴의 제조법
JPS63201194A (ja) モノアルキルリン酸エステルの製造および分離方法
EP1213294B2 (en) Purifying process for phosphatidylserine
AU766255B2 (en) Improved process for phosphorylation and compounds produced by this process
EP0217765B1 (en) Process for the preparation of l-alpha-glycerylphosphorylcholine, l-alpha-glycerylphosphorylethanolamine from crude and/or deoleated lecithins
CH630090A5 (en) Process for preparing phosphoric esters of ascorbic acid
EP0582924A1 (de) Verfahren zur Herstellung von Calcium-L-ascorbat-2-phosphat
JPS6336792A (ja) 酵素によるリン脂質の製造方法
GB2065659A (en) Calciumphosphatidylchlorine- chloride, process for producing the same and pharmaceutical preparations containing the same
JPS6341920B2 (https=)
JPS58179437A (ja) 高含量のホスフアチジルコリンを有する粗製物の製造方法
RU2058787C1 (ru) Способ получения лецитина
DE60007201T2 (de) Verfahren zur Herstellung von Ascorbinsaüre-2-Monophosphat salz
KR102433277B1 (ko) 유지를 이용한 콜린알포세레이트 조성물의 제조 방법
CN1263098A (zh) 饱和磷脂酸及其盐类的制备方法
US4252949A (en) Monoesters of pyrazinetetracarboxylic acid
DE4220852C2 (de) Verfahren zur Herstellung von Alkylphosphocholinen und Reinherstellung derselben
CN117736807A (zh) 一种脂肪酶改性大豆磷脂的方法
RU1085210C (ru) Способ получени @ -циклоцитидин- @ -монофосфата и его производных
AT382623B (de) Verfahren zur herstellung von kephalinen und kephalin analogen verbindungen und phosphatidyl- glykolverbindungen und deren analogen
JPH10237081A (ja) クロマノール誘導体およびその製造方法並びに抗酸化剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20011107

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20011108

Comment text: Request for Examination of Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20030206

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20031129

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20040722

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20031129

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I